Share on Pinterest New research suggests that eating more protein while taking GLP-1 drugs could help prevent muscle loss. Stocksy United Increasing protein intake while taking GLP-1 drugs for weight ...
This early research offers important insight into how weight loss with medication can affect your body in ways you might not expect. Semaglutide and Muscle Loss: A Hidden Side Effect Semaglutide, part ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost fitness and can cause serious muscle loss, potentially undermining the ...
GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with fat, experts say. Photo by Adobe Stock/HealthDay News GLP-1 drugs like ...
A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and similar GLP-1 agonists, but without muscles loss as a potential ...
A combination treatment of semaglutide, trevogrumad and garetosmab causes fat loss and muscle growth in primate trials. Full trial results for humans are expected later in 2025. Results from the Phase ...
You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists like Ozempic®, Wegovy®, Mounjaro®, and Zepbound®. While Ozempic can be great ...
In adults with obesity who were prescribed semaglutide, older age and female sex were associated with greater muscle loss, whereas a higher protein intake appeared to be protective against this loss.
GLP-1s may shrink the scale, but they can also shrink your muscle, especially your heart. When you stop the meds, dangerous belly fat often comes back fast and harder than before. Dr. Sean O’Mara ...
Increasing protein intake while taking GLP-1 drugs for weight loss could help prevent muscle loss, according to a new study. As a common side effect of weight loss, muscle loss could also lead to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results